WISE S.r.l. (Wiringless Implantable Stretchable Electronics) is a start-up company, created in 2011, having the mission to develop the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson.
WISE bases its activity on an innovative and patented technology, named “Supersonic Cluster Beam Implantation” (SCBI - PCT/EP2011/054903), enabling to embed inside of elastomers stretchable circuits capable to resist without electrical failure to extensive deformations of the polymer, as bending and stretching. Furthermore and having very good performances in terms of biocompatibility. WISE is using its proprietary technology for producing a completely new family of leads for neuromodulation (implanted in the spinal cord or brain of patients for treating neurodegenerative diseases) that will be more reliable, less invasive and cheaper compared to existing products: this will make WISE a key player in the NM market.
WISE bases its activity on an innovative and patented technology, named “Supersonic Cluster Beam Implantation” (SCBI - PCT/EP2011/054903), enabling to embed inside of elastomers stretchable circuits capable to resist without electrical failure to extensive deformations of the polymer, as bending and stretching. Furthermore and having very good performances in terms of biocompatibility. WISE is using its proprietary technology for producing a completely new family of leads for neuromodulation (implanted in the spinal cord or brain of patients for treating neurodegenerative diseases) that will be more reliable, less invasive and cheaper compared to existing products: this will make WISE a key player in the NM market.
Location: Italy
Employees: 11-50
Total raised: $62.65M
Founded date: 2011
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 19.06.2026 | Series D | $34.38M | European I... |
| 01.10.2020 | Series C | $17.62M | - |
| 26.05.2017 | Series B | $7.27M | - |
| 15.06.2015 | Series A | $3.38M | - |
Mentions in press and media 20
| Date | Title | Description |
| 19.06.2026 | WISE Raises €30 Million Series D To Advance Implantable Neurotechnology | WISE announced the closing of an oversubscribed €30 million Series D financing round. The round was joined by ENEA Tech and Biomedical, an Italian foundation focused on innovation and technology transfer in the biomedical sector. ENEA Tech ... |
| 11.07.2025 | WISE SpA first to achieve MDR certification of cortical strip for Neuromonitoring | WISE Cortical Strip WISE SpA Manufacturing The WISE Cortical Strip (WCS®) is the first cortical strip for Intraoperative Neurophysiological Monitoring (IONM) to achieve CE mark under MDR (1) MILAN, ITALY, July 11, 2025 /EINPresswire.com/ --... |
| 30.07.2024 | WISE Completes New Financing Round to Accelerate Development of Heron® Lead | MILAN, ITALY, July 30, 2024 /EINPresswire.com/ -- • The Heron® lead is the first unidirectional multicolumn lead for spinal cord stimulation that can be implanted percutaneously for chronic pain treatment. • The new financing round, worth €... |
| 14.05.2024 | WISE S.r.l. & Axontronic GmbH sign exclusive distribution agreement of the WISE Cortical Strip in Germany and Austria | WISE S.r.l., is a pioneering medical device company developing advanced electrodes for neuromonitoring, neuromodulation, and brain-machine interfacing (BMI) MILAN, ITALY, May 14, 2024 /EINPresswire.com/ -- WISE S.r.l., a pioneering medical ... |
| 30.04.2024 | Neuromodulation tech company raises $27.5M, hires new CEO | - |
| 01.10.2020 | Neuromodulation pioneer WISE closes EUR 15M Series C financing round to launch second product, SCS EXPERT | - |
| 01.10.2020 | Wise Closes €15M Series C Financing | Wise Srl, an Italian medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, closed a €15m Series C financing round. New investors, led by CDP Venture Capital S... |
| 29.09.2017 | Wise, l’ultimo round raccoglie 6 milioni e mezzo! | Un round di finanziamento ogni due anni, in aumento costante. Questa è la media con cui viaggia Wise, una società biomedicale che sta sviluppando un’innovativa generazione di elettrodi impiantabili per neuromodulazione. Questo ultimo round... |
| 26.05.2017 | Wise Raises €6.5M in Series B Funding | Wise Srl, a Cologno Monzese, Milan, Italy-based medical device company developing next-generation implantable neuromodulation leads, closed a €6.5m Series B financing. The round was led by Principia SGR, with participation from existing inv... |
| 26.05.2017 | Term Sheet — Friday, May 26 | OPEN MIC Good morning. Term Sheet will be off Monday for Memorial Day. Which means it’s the Friday before a long weekend. Which means it’s time for some feedback. Strap in! Paid Content You can't secure what you can't see From ExtraHop DS w... |
Show more